ILIAS Biologics
Latest round
- Series B
Last raised
- Sep 2020
Total raised
- $37M
Investors
- 16
About ILIAS Biologics
Founded in 2015 and based in Daejeon, South Korea, ILIAS Biologics Inc. is a biotechnology company that focuses on developing therapeutic molecules as potential treatments for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
Who invested in ILIAS Biologics
16 investors across 2 rounds
See all investors in ILIAS Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ILIAS Biologics
Who invested in ILIAS Biologics?
ILIAS Biologics has 16 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ILIAS Biologics raised?
ILIAS Biologics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ILIAS Biologics last raise money?
ILIAS Biologics's most recent round on record is a Series B, in Sep 2020.
What does ILIAS Biologics do?
Founded in 2015 and based in Daejeon, South Korea, ILIAS Biologics Inc.
Where is ILIAS Biologics headquartered?
ILIAS Biologics is headquartered in Daejeon, South Korea.
Which VCs invest in companies like ILIAS Biologics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ILIAS Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ILIAS Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.